case_images: PMC6260726_01
case_images: T2W screening images of uterine fibroids (red asterisks) in a) the sagittal and b) axial plane
case_images: 40349_2018_116_Fig3_HTML.jpg
case_images: PMC6260726_01_40349_2018_116_Fig3_HTML.jpg
case_images: Fig3
case_images: Funaki type I based on T2W images, and contrast-enhanced T1W images were assessed. Fibroid sizes were 5.0 x 4.6 x 4.8 cm3, 2.5 x 1.3 x 2.0 cm3, and 2.8 x 1.9 x 2.4 cm3 (Fig. 3).  
case_images: T2W planning images displayed on the therapy planning console with ultrasound beam view where bowels are presented with red color and target uterine fibroid not accessible with blue color
case_images: 40349_2018_116_Fig4_HTML.jpg
case_images: PMC6260726_01_40349_2018_116_Fig4_HTML.jpg
case_images: Fig4
case_images: T2W planning images displayed on the therapy planning console with ultrasound beam view after application of wedged gel pad where red color boundary is bowels, blue is uterine fibroid, and green is the gel pad
case_images: 40349_2018_116_Fig5_HTML.jpg
case_images: PMC6260726_01_40349_2018_116_Fig5_HTML.jpg
case_images: Fig5
case_images: Contrast enhanced T1W images immediately after the treatment (NPVs: 86% and 39%) and at 3-month follow-up (Shrinkages: 49% and 2.5%)
case_images: 40349_2018_116_Fig6_HTML.jpg
case_images: PMC6260726_01_40349_2018_116_Fig6_HTML.jpg
case_images: Fig6
case_images: T1W images were acquired, indicating non-perfused volume ratios (NPVs) of 86% and 39% (Fig. 6). There were no areas of abnormal enhancement within the subcutaneous tissue, and skin was normal after treatment. The volume and shrinkage of the fibroids at 3 months follow-up were 29 mL and 49%, 5 mL and 2.5% respectively (Fig. 6).
case_images: PMC6260726_02
case_images: T2W screening images of uterine fibroid (red asterisk) in a) the sagittal and b) axial plane
case_images: 40349_2018_116_Fig7_HTML.jpg
case_images: PMC6260726_02_40349_2018_116_Fig7_HTML.jpg
case_images: Fig7
case_images: Funaki type II based on T2W images, and contrast-enhanced T1W images were assessed. Fibroid size was 5.7 x 5.0 x 5.0 cm3 (Fig. 7).  
case_images: T2W planning images displayed on the therapy console with ultrasound beam view where bowels are presented with red boundary and uterine fibroid with blue boundary
case_images: 40349_2018_116_Fig8_HTML.jpg
case_images: PMC6260726_02_40349_2018_116_Fig8_HTML.jpg
case_images: Fig8
case_images: T2W planning images displayed on the therapy console with ultrasound beam view after application of wedged gel pad where red boundary is bowel, blue is uterine fibroid and green is the gel pad
case_images: 40349_2018_116_Fig9_HTML.jpg
case_images: PMC6260726_02_40349_2018_116_Fig9_HTML.jpg
case_images: Fig9
case_images: Contrast enhanced T1W images in a) sagittal and b) axial plane immediately after the treatment (NPV: 3%)
case_images: 40349_2018_116_Fig10_HTML.jpg
case_images: PMC6260726_02_40349_2018_116_Fig10_HTML.jpg
case_images: Fig10
case_images: Immediately after the treatment, contrast enhanced T1W images were acquired, showing non-perfused volume ratio (NPV) of only 3% (Fig. 10).